Closing the door on KRAS-mutant lung cancer

被引：5
|
作者：
Cully, Megan
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 11期
关键词：
D O I：
10.1038/nrd.2016.216
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：747 / 747
页数：1
相关论文
共 50 条
  • [31] Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model
    Lee, Jong Woo
    Zhang, Yu
    Choi, Justin
    Sharma, Roshan
    Park, Hee Sun
    Kaftan, Edward
    Papadimitrakopoulou, Vassiliki
    Herbst, Roy
    Koo, J. Peter
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1319 - S1319
  • [32] Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.
    Arbour, Kathryn Cecilia
    Ricciuti, Biagio
    Rizvi, Hira
    Hellmann, Matthew D.
    Yu, Helena Alexandra
    Ladanyi, Marc
    Kris, Mark G.
    Arcila, Maria E.
    Rudin, Charles M.
    Lito, Piro
    Awad, Mark M.
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma
    Boiarsky, D.
    Lydon, C. A.
    Chambers, E. S.
    Sholl, L. M.
    Nishino, M.
    Skoulidis, F.
    Heymach, J., V
    Luo, J.
    Awad, M. A.
    Janne, P. A.
    Van Allen, E. M.
    Barbie, D. A.
    Vokes, N. I.
    ANNALS OF ONCOLOGY, 2023, 34 (07) : 589 - 604
  • [34] Development of siRNA Payloads to Target KRAS-Mutant Cancer
    Yuan, Tina L.
    Fellmann, Christof
    Lee, Chih-Shia
    Ritchie, Cayde D.
    Thapar, Vishal
    Lee, Liam G.
    Hsu, Dennis J.
    Grace, Danielle
    Carver, Joseph O.
    Zuber, Johannes
    Luo, Ji
    McCormick, Frank
    Lowe, Scott W.
    CANCER DISCOVERY, 2014, 4 (10) : 1182 - 1197
  • [35] Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
    El Osta, Badi
    Behera, Madhusmita
    Kim, Sungjin
    Berry, Lynne D.
    Sica, Gabriel
    Pillai, Rathi N.
    Owonikoko, Taofeek K.
    Kris, Mark G.
    Johnson, Bruce E.
    Kwiatkowski, David J.
    Sholl, Lynette M.
    Aisner, Dara L.
    Bunn, Paul A.
    Khuri, Fadlo R.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 876 - 889
  • [36] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
    Zhang Yang
    Shun-Qing Liang
    Liang Zhao
    Haitang Yang
    Thomas M. Marti
    Balazs Hegedüs
    Yanyun Gao
    Bin Zheng
    Chun Chen
    Wenxiang Wang
    Patrick Dorn
    Gregor J. Kocher
    Ralph A. Schmid
    Ren-Wang Peng
    Journal of Experimental & Clinical Cancer Research, 41
  • [38] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Xiaoqing Luo
    Shunli Peng
    Sijie Ding
    Qin Zeng
    Rong Wang
    Yueyun Ma
    ShiYu Chen
    Yanxia Wang
    Wei Wang
    Cancer Cell International, 21
  • [39] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Jacqueline V. Aredo
    Sukhmani K. Padda
    Current Treatment Options in Oncology, 2018, 19
  • [40] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.
    Boumelha, Jesse
    de Carne, Sophie
    Mugarza, Edurne
    Romero-Clavijo, Pablo
    Molina-Arcas, Miriam
    Downward, Julian
    CANCER RESEARCH, 2021, 81 (13)
12345